<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04225442</url>
  </required_header>
  <id_info>
    <org_study_id>834156</org_study_id>
    <nct_id>NCT04225442</nct_id>
  </id_info>
  <brief_title>The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions</brief_title>
  <official_title>The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators piloted the characterization of the human chronobiome. Now, this line of
      research is extended to explore physiological chronobiome modulated by sex, age and under
      evoked conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      &quot;Is your body clock important? Absolutely. Just ask any morning lark who lives with a night
      owl, or vice versa&quot;. This quote from a piece published in the Philadelphia Inquirer about the
      investigator's work illustrates the importance of time in one's personal preferences
      [https://www.inquirer.com/health/chronobiome-body-clock-university-pennsylvania-20190307.html
      ].

      Several decades of research have found out that how well a person functions, very much
      depends on how much this person is in harmony with her/his own preferences and environment.
      This harmony is acutely disturbed when one travels quickly across several time zones, because
      suddenly the body's physiology is still following the departure time but the arrival time
      tells the body something different. As a result, travelers often experience sleep problems
      and indigestion, which usually disappear after a couple of days. This is different in
      long-term shift workers for whom work outside of the typical daylight hours means that they
      have a higher risk for diseases including cardiovascular diseases, diabetes and cancer.

      Another observation has been that many diseases occur or worsen at a specific time of day.
      Heart attacks, for example, most often occur when patients wake up in the morning. Shortness
      of breath peaks at 4 am in the morning for patients with asthma.

      Intriguingly, more and more studies suggest that time of day matters how effective drugs work
      and how many side effects one might experience. To study this the investigators started to
      describe the human chronobiome, which foremost looks at time of day differences of a person's
      physiology, for example, in the small pilot study the investigators saw a difference in break
      down products, or metabolites, between mornings and evenings. Now, in this present study, the
      investigators wish to extend the understanding how the human chronobiome differs between
      healthy men and women, healthy young and old and how it reacts to a fatty meal challenge.

      This knowledge will help the investigators to say when a finding can still be considered
      normal or maybe indicates a first sign of disease. The novelty of this approach is that the
      investigators measure long enough to understand the role of time of day for a person's
      chronobiome, that the investigators measure many things to obtain a comprehensive
      representation of a person's chronobiome, that every measure is timestamped, and that the
      investigators ask participants to eat fatty meals to see how the chronobiome changes.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID-19
  </why_stopped>
  <start_date type="Actual">January 5, 2020</start_date>
  <completion_date type="Anticipated">June 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 4, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent difference in the number of proteins with post-translational modifications found in blood samples from young versus old participants</measure>
    <time_frame>48 hours</time_frame>
    <description>High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect age has on the number of proteins with post-translational modifications.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants</measure>
    <time_frame>48 hours</time_frame>
    <description>High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect sex has on the number of proteins with post-translational modifications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants and by age</measure>
    <time_frame>48 hours</time_frame>
    <description>High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore whether an interaction between age and sex has an effect on the number of proteins with post-translational modifications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in environmental light exposure between young versus old participants</measure>
    <time_frame>48 hours</time_frame>
    <description>Wrist actigraphy collects personal light exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in environmental light exposure between young versus old participants and by sex</measure>
    <time_frame>48 hours</time_frame>
    <description>Wrist actigraphy collects personal light exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in physical activity between young versus old participants</measure>
    <time_frame>48 hours</time_frame>
    <description>Wrist actigraphy records accelerometer data to calculate physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in physical activity between young versus old participants and by sex</measure>
    <time_frame>48 hours</time_frame>
    <description>Wrist actigraphy records accelerometer data to calculate physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in systolic blood pressure readings between young versus old participants</measure>
    <time_frame>48 hours</time_frame>
    <description>Ambulatory blood pressure measurements (ABPM) collect blood pressure readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent difference in systolic blood pressure readings between young versus old participants and by sex</measure>
    <time_frame>48 hours</time_frame>
    <description>Ambulatory blood pressure measurements (ABPM) collect blood pressure readings</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Healthy</condition>
  <condition>Healthy Aging</condition>
  <arm_group>
    <arm_group_label>Fatty meal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>To study how a fatty meal modifies the physiological chronobiome in young and old, an isocaloric controlled liquid high fat meal (ICLHFM) will be consumed within 5 min. The ICLHFM contains an equivalent to 35% of the estimated total daily energy requirements (TDE), 60% of kcal delivered from fat while 13% come from protein and 27 % from carbohydrate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fatty meal to challenge the physiological chronobiome in healthy young and old</intervention_name>
    <description>The intervention consists of a fatty meal</description>
    <arm_group_label>Fatty meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Young: 18-30 years of age, Old: 55-75 years of age

          2. Apparent healthy

          3. BMI (body mass index) up to 27.4

          4. Upper arm with intact skin, i.e. without areas of breached or injured skin visible,
             for ambulatory blood pressure (ABP) measurements,

          5. Own and use a smartphone.

        Exclusion Criteria:

          1. History of severe psychiatric illness or cognitive conditions, for example (mania,
             schizophrenia, or mental retardation;

          2. Shift work, defined as recurring work between 22:00-05:00;

          3. A diagnosis of clinically significant obstructive sleep apnea;

          4. Serum creatinine &gt; 1.5 mg/dl in men or &gt;1.3 mg/del in women;

          5. Significant liver disease (&gt;3x upper limit of normal);

          6. Diabetes mellitus;

          7. Past diagnosis of gastroesophageal reflux disease,

          8. Transmeridian travel across ≥3 time zones in the two weeks before the 48hr deep
             phenotype sessions;

          9. Use of oral or intravenous antibiotics in the 6 months prior to enrollment;

         10. Subjects, who have received an experimental drug, used an experimental medical device
             within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8
             weeks prior to screening;

         11. &gt; 2 drinks of alcohol per day;

         12. Use of drugs assessed in the urinary drug test;

         13. Nursing or pregnant (pregnancy will be repeatedly assessed at the beginning of each of
             the four inpatient visits, i.e. prior to the start of blood draws);

         14. Use of pacemaker or implantable Cardioverter Defibrillator (ICD);

         15. Bilateral mastectomy;

         16. History of Raynaud's phenomenon;

         17. Known allergy against natural latex rubber (contained in ABP bladder and tubing);

         18. Subjects taking medication with alpha-blockers.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Garret A FitzGerald, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carsten C Skarke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.inquirer.com/health/chronobiome-body-clock-university-pennsylvania-20190307.html</url>
    <description>Philadelphia Inquirer</description>
  </link>
  <reference>
    <citation>Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.</citation>
    <PMID>29215023</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronobiome</keyword>
  <keyword>Multiomics</keyword>
  <keyword>Molecular networks</keyword>
  <keyword>Circadian clocks</keyword>
  <keyword>Remote sensing</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

